<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>CARBATUSS - carbetapentane citrate, phenylephrine hydrochloride and guaifenesin liquid </strong><br>GM Pharmaceuticals, Inc.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>CARBATUSS</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>DESCRIPTION:</h1>Revised Formula<br>NDC 58809-536-01<br><br>CARBATUSS is an alcohol-free, red liquid for oral administration having a spearmint odor and flavor.<br><br>Each teaspoonful (5 mL) contains:<br>Carbetapentane Citrate..........................20 mg<br>Phenylephrine Hydrochloride..................10 mg<br>Guaifenesin........................................100 mg<br>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY:</h1>Carbetapentane Citrate is a centrally acting non-narcotic antitussive.  Phenyleprine HCl is a sympathomimetic which acts predominantly on alpha receptors and have little action on beta receptors.  They therefore function as oral nasal decongestants with minimal CNS stimulation.  Guaifenesin has an expectorant action which increases the output of respiratory tract fluid by reducing adhesiveness and surface <span class="product-label-link" type="condition" conceptid="4200706" conceptname="Tension">tension</span>.  Sinus and bronchial drainage is improved and dry, nonproductive <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">coughs</span> become more productive and less frequent.<br>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>INDICATIONS &amp; USAGE:</h1>For temporary relief of nonproductive <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span> accompanying <span class="product-label-link" type="condition" conceptid="4170108" conceptname="Respiratory tract congestion">respiratory tract congestion</span> associated with the <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">common cold</span>, <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span>, <span class="product-label-link" type="condition" conceptid="4283893" conceptname="Sinusitis">sinusitis</span>, and <span class="product-label-link" type="condition" conceptid="256451" conceptname="Bronchitis">bronchitis</span>.<br>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS:</h1>CARBATUSS is contraindicated in infants and newborns, and in patients with known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the components.  It is also contraindicated in patients with severe <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, severe <span class="product-label-link" type="condition" conceptid="317576" conceptname="Coronary arteriosclerosis">coronary artery disease</span>, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, and in patients on MAO inhibitor therapy.  Patient idiosyncrasy to adrenergic agents may be manifested by <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, or <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span>.<br>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<h1>WARNINGS:</h1>Sympathomimetic amines should be used with caution in patients with <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, <span class="product-label-link" type="condition" conceptid="4124683" conceptname="Silent myocardial ischemia">ischemic heart disease</span>, <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span> mellitus, <span class="product-label-link" type="condition" conceptid="4011560" conceptname="Raised intraocular pressure">increased intraocular pressure</span>, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, or <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span>.  Sympathomimetics may produce central nervous system stimulation with <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span> or <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">cardiovascular collapse</span> with accompanying <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>.<br><br><span class="Bold">DO NOT EXCEED RECOMMENDED DOSAGE.</span><br>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>PRECAUTIONS:</h1>Drug Interactions: <br>MAO inhibitors and beta adrenergic blockers increase the effects of sympathomimetics.  Sympathomimetics may reduce the hypertensive effects of methyldopa, mecamylamine, reserpine, and veratrum alkaloids,  Guaifenesin may produce an increase in urinary 5-hydroxy-indoleacetic acid and may therefore interfere with the interpretation of this test for the diagnosis of <span class="product-label-link" type="condition" conceptid="199771" conceptname="Carcinoid syndrome">carcinoid syndrome</span>.  It may also falsely elevate the VMA test for catechols.  Administration of this drug should be discontinued 48 hours prior to the collections of urine specimens for such tests.<br>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-7"></a><p></p>
<h1>CARCINOGENESIS, MUTAGENESIS, AND IMPAIRMENT OF FERTILITY:</h1>No adequate and well controlled studies have been conducted to determine whether the components of CARBATUSS have a potential for carcinogenesis, mutagenesis, or impairment of fertility.<br>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-8"></a><p></p>
<h1>PREGNANCY:</h1>Pregnancy Category C:<br>Animal reproduction studies have not been conducted with this product.  It is also not known whether it can cause fetal harm when administered to a pregnant woman or can effect reproduction capacity.  This product should not be administered to pregnant women.<br>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-9"></a><p></p>
<h1>NURSING MOTHERS:</h1>Due to the possible passage of the ingredients into breast milk, this product should not be given to nursing mothers.<br>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-10"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>Mild central nervous system stimulation, especially in those patients who are hypersensitive to sympathomimetic drugs, may occur.  <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">Nervousness</span>, <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">excitability</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, and <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span> may also occur.  <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span> and <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> have also been reported.  Large doses may cause <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">lightheadedness</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> and/or <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>.  Sympathomemitic drugs have also been associated with certain untoward reactions including <span class="product-label-link" type="condition" conceptid="4029621" conceptname="Fear">fear</span>, <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">anxiety</span>, <span class="product-label-link" type="condition" conceptid="4136244" conceptname="Feeling tense">tenseness</span>, <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">anxiety</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="4260836" conceptname="Blanching of skin">pallor</span>, respiratory difficulty, <span class="product-label-link" type="condition" conceptid="197684" conceptname="Dysuria">dysuria</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucination</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsion</span>, <span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span>, and <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">cardiovascular collapse</span> with <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>.<br>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-11"></a><p></p>
<h1>OVERDOSAGE:</h1>Signs And Symptoms:<br>Central effects include <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4137162" conceptname="Overactive">hyperactive</span> reflexes, <span class="product-label-link" type="condition" conceptid="4294887" conceptname="Cluttering">talkativeness</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span> and <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>.  Cardiovascular and renal effects include difficulty in urination, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitation</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span> with subsequent <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> and <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">circulatory collapse</span>.  Gastrointestinal effects include <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>, <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, and <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal cramps</span>.<br><br><span class="Bold">TREATMENT:</span><br>The patient should be induced to vomit, even if <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span> has occurred spontaneously.  Pharmacologic <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> by administration of ipecac syrup is a preferred method, however, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> should not be induced in patients with impaired consciousness.  Precautions against <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">aspiration</span> must be taken, especially in infants and children.  Following <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span>, any drug remaining in th stomach may be absorbed by activated charcoal administered as a slurry with water.  Treatment of the signs and symptoms of overdosage is symptomatic and supportive.<br>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-12"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>CARBATUSS is administered orally as follows:  <span class="Bold">Adults: </span> 1-2 teaspoonfuls every 4-6 hours or as directed by a physician.  <span class="Bold">Children 6-12 Years:</span>  1 teaspoonful every 4-6 hours or as directed by a physician.<br>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-13"></a><p></p>
<h1>HOW SUPPLIED:</h1>16 Fluid ounce bottles NDC 58809-536-01 and 15 mL bottles NDC 58809-536-02<br><br>Tamper evident by heat seal under cap.  Do not used if there is evidence of tampering.<br><br><span class="Bold">KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.  IN CASE OF ACCIDENTAL OVERDOSAGE, CONTACT A POISON CONTROL CENTER AND SEEK PROFESSIONAL ASSISTANCE IMMEDIATELY.</span><br><br><span class="Bold">STORE AT CONTROLLED ROOM TEMPERATURE BETWEEN 59° -  86°F (15° - 30°C)</span><br><br>Dispense in a tight, light-resistant container with a child-resistant closure as described in the USP/NF.<br><br><span class="Bold">Distributed by:</span><br>GM Pharmaceuticals, Inc.,<br>Arlington, TX  76012<br><span class="Bold"><br>Rx Only</span><br><br>Rev. 09/10<br>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-14"></a><p></p>
<h1>PRODUCT PACKAGING:</h1>The packaging below represents the labeling currently used:<br><br>Principal Display Panel and Side Panel for 473 mL Label:<br><br><span class="Bold">NDC 58809-536-01<br></span><br>REVISED FORMULA<br><span class="Bold"><br>CARBATUSS<br></span><br>Antitussive / Decongestant / Expectorant<br><br>EACH 5 mL (1 TEASPOONFUL) CONTAINS:<br><br>Carbetapentane Citrate................................20 mg<br>Phenylephrine Hydrochloride........................10 mg<br>Guaifenesin..............................................100 mg<br><br><span class="Bold">Rx Only</span><br><br><span class="Bold">ONE PINT (473 mL)</span><br><br>GM PHARMACEUTICALS, INC.<br><br><span class="Bold">USUAL DOSAGE:</span><br><span class="Bold">Adults: </span>  1-2 teaspoonfuls every 4-6 hours or as directed by a physician.<br><span class="Bold">Children 6-12 years of age: </span> 1 teaspoonful every 4-6 hours or as directed by a physician.<br><br><span class="Bold">For full prescribing information see package insert.</span><br><br><span class="Bold">DISPENSE: </span> In a tight, light-resistant container with a child-resistant closure as described in the USP/NF.<br><br>Tamper evident by heat seal under cap.  Do not use if there is evidence of tampering.<br><br><span class="Bold">STORE AT CONTROLLED ROOM TEMPERATURE<br>BETWEEN 59° - 86°F (15° - 30°C)<br><br>KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSAGE, CONTACT A POISON CONTROL CENTER AND SEEK PROFESSIONAL ASSISTANCE IMMEDIATELY.<br></span><br><span class="Bold">Distributed by:</span><br>GM Pharmaceuticals, Inc.<br>Arlington, TX  76012<br><br><span class="Bold">Rx Only</span><br><br>Rev. 09/10<br><br><div class="Figure"><img alt="CARBATUSS Packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8d886ec3-8ccf-4fd0-84d6-de9e858da0fb&amp;name=MM1.jpg"></div>
<br><div class="Figure"><img alt="CARBATUSS Packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8d886ec3-8ccf-4fd0-84d6-de9e858da0fb&amp;name=MM2.jpg"></div>
<br><br><div class="Figure"><img alt="CARBATUSS Packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8d886ec3-8ccf-4fd0-84d6-de9e858da0fb&amp;name=MM3.jpg"></div>
<br><br>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>CARBATUSS 		
					</strong><br><span class="contentTableReg">carbetapentane citrate, phenylephrine hydrochloride, guaifenesin liquid</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:58809-536</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Carbetapentane Citrate</strong> (Carbetapentane) </td>
<td class="formItem">Carbetapentane Citrate</td>
<td class="formItem">20 mg  in 5 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>Phenylephrine Hydrochloride</strong> (Phenylephrine) </td>
<td class="formItem">Phenylephrine Hydrochloride</td>
<td class="formItem">10 mg  in 5 mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Guaifenesin</strong> (Guaifenesin) </td>
<td class="formItem">Guaifenesin</td>
<td class="formItem">100 mg  in 5 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">    </td>
<td class="formLabel">Score</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem">SPEARMINT</td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:58809-536-01</td>
<td class="formItem">473 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:58809-536-02</td>
<td class="formItem">15 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">11/01/2000</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>GM Pharmaceuticals, Inc.
							(793000860)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 12/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>c28eb54a-8b11-4174-afc3-3330dace34a3</div>
<div>Set id: 8d886ec3-8ccf-4fd0-84d6-de9e858da0fb</div>
<div>Version: 1</div>
<div>Effective Time: 20101230</div>
</div>
</div> <div class="DistributorName">GM Pharmaceuticals, Inc.</div></p>
</body></html>
